Michael G. Kauffman
2015
In 2015, Michael G. Kauffman earned a total compensation of $4.6M as Chief Executive Officer at Karyopharm Therapeutics, a 602% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $150,000 |
---|---|
Option Awards | $3,896,500 |
Salary | $500,000 |
Other | $10,980 |
Total | $4,557,480 |
Kauffman received $3.9M in option awards, accounting for 85% of the total pay in 2015.
Kauffman also received $150K in non-equity incentive plan, $500K in salary and $11K in other compensation.
Rankings
In 2015, Michael G. Kauffman's compensation ranked 1,820th out of 13,638 executives tracked by ExecPay. In other words, Kauffman earned more than 86.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,820 | 87th |
Manufacturing | 655 | 87th |
Chemicals And Allied Products | 241 | 87th |
Drugs | 187 | 88th |
Pharmaceutical Preparations | 150 | 87th |
Kauffman's colleagues
We found three more compensation records of executives who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2015.
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019